SOPHiA GENETICS SA·4

Apr 21, 4:04 PM ET

Valente Manuela 4

4 · SOPHiA GENETICS SA · Filed Apr 21, 2026

Research Summary

AI-generated summary of this filing

Updated

SOPHiA GENETICS (SOPH) CPO Manuela Valente Sells 380 Shares

What Happened

  • Manuela Valente, Chief People Officer of SOPHiA GENETICS SA (SOPH), sold 380 shares on April 20, 2026. The weighted average sale price was $5.20 per share for total proceeds of approximately $1,977. This was a sale (not a buy) and is a routine disposition related to tax obligations, not an expressed bullish signal.

Key Details

  • Transaction date: 2026-04-20 (filed with the SEC on 2026-04-21; filing is within the typical 2-business-day window).
  • Sale details: 380 shares sold; weighted average price $5.20; price range across multiple trades $5.10–$5.29 (Reporting Person can provide per-price breakdown on written request).
  • Reason/footnotes: Shares were sold in the open market to satisfy tax withholding for RSUs that vested on April 18, 2026. Sales were effected under a pre-established Rule 10b5-1(c) trading plan and were non-discretionary.
  • Shares owned after transaction: Not specified in the provided Form 4.

Context

  • This was a tax-withholding sale tied to RSU vesting (common for executives) and executed under a 10b5-1 plan; such transactions are routine and do not necessarily indicate a change in insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-04-20
Valente Manuela
Chief People Officer
Transactions
  • Sale

    Ordinary Shares

    [F1][F2]
    2026-04-20$5.20/sh380$1,977215,071 total
Footnotes (2)
  • [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Manuela Valente|2026-04-21

Documents

1 file
  • 4
    wk-form4_1776801885.xmlPrimary

    FORM 4